2014
DOI: 10.1016/j.fct.2014.01.044
|View full text |Cite
|
Sign up to set email alerts
|

Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
68
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 76 publications
(71 citation statements)
references
References 46 publications
3
68
0
Order By: Relevance
“…A potential limitation of the study is the use of native phenolic compounds present in the powders instead of their microbiota/liver metabolites. Current evidences indicate that flavonoid metabolites produced by colonic microbiota, especially those of phenolic acids (di-and mono-hydroxylated phenylpropionic, phenylacetic and benzoic acids), could possess biological properties and therefore potential health beneficial effects (Fernández-Millán et al, 2014). These results support the hypothesis that not only food polyphenols but also their microbial metabolites must be taken into account when assessing the impact of polyphenols on health.…”
Section: Discussionsupporting
confidence: 54%
“…A potential limitation of the study is the use of native phenolic compounds present in the powders instead of their microbiota/liver metabolites. Current evidences indicate that flavonoid metabolites produced by colonic microbiota, especially those of phenolic acids (di-and mono-hydroxylated phenylpropionic, phenylacetic and benzoic acids), could possess biological properties and therefore potential health beneficial effects (Fernández-Millán et al, 2014). These results support the hypothesis that not only food polyphenols but also their microbial metabolites must be taken into account when assessing the impact of polyphenols on health.…”
Section: Discussionsupporting
confidence: 54%
“…In addition, EC inhibited the IL‐1β‐induced expression of inducible nitric oxide synthase by blocking the nuclear localization of the p65‐nuclear factor kappa B (NF‐κB) and partly restored the insulin in RINm5F cells . Likewise, EC promoted glucose‐stimulated insulin secretion in rat β‐pancreatic INS‐1E cells , and a similar effect was observed with the microbial‐derived flavonoid metabolites 3,4‐dihydroxyphenylacetic acid (5 μM), and 3‐hydroxyphenylpropionic acid (1 μM) in the same cell line as well as in rat pancreatic islets . Nevertheless, it has been showed that at lower concentrations EC and procyanidin B2 (0.01–0.32 μM) inhibited and did not modify insulin secretion, respectively, in INS‐1E cells .…”
Section: Antidiabetic Actions Of Cocoa Flavonoidsmentioning
confidence: 74%
“…In addition, flavanol oligomers and polymers that are not absorbed through the gut barrier (large proanthocyanidins appear to be 10‐ to 100‐fold less absorbed ) could be metabolized by the intestinal microbiota into different phenolic acids of low molecular weight, which are more bioavailable, and might be well absorbed through the colon and exert beneficial effects . Consequently, the formation of various polyphenol‐derived phenolic acids, such as m‐ hydroxyphenylpropionic acid, m ‐hydroxyphenylacetic acid, as well as m ‐hydroxybenzoic acid, were shown to be increased in humans and rats after cocoa consumption and to possess an antidiabetic potential by in vitro studies .…”
Section: Cocoa Flavonoidsmentioning
confidence: 99%
“…The global prevalence of DM has risen to 8.5% amounting ∼422 million in 2014 (World Health Organization [WHO], 2016). It has been predicted that, the incidence of this syndrome would be more than double by the year of 2030 (Fernández-Millán et al, 2014). Amongst all diagnosed cases, type 2 diabetes mellitus (T2DM) is more rampant and comprising ∼90–95% of total diabetic cases (Khanra et al, 2015).…”
Section: Introductionmentioning
confidence: 99%